Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins - PubMed (original) (raw)
. 2005 Dec 1;48(24):7781-8.
doi: 10.1021/jm040208l.
Affiliations
- PMID: 16302817
- DOI: 10.1021/jm040208l
Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins
Timothy Hill et al. J Med Chem. 2005.
Abstract
Dynamin I is a GTPase enzyme required for endocytosis and is an excellent target for the design of potential endocytosis inhibitors. Screening of a library of tyrphostins, in our laboratory, against the GTPase activity of dynamin I gave rise to a microM potent lead, 2-cyano-3-(3,4-dihydroxyphenyl)thioacrylamide (1, IC50 70 microM). Our initial investigations suggested that only the dimeric form of 1 displayed dynamin I GTPase inhibitory activity. Subsequent synthetic iterations were based on dimeric analogues and afforded a number of small molecules, low microM potent, inhibitors of dynamin I GTPase, in particular, symmetrical analogues with a minimum of two free phenolic -OHs: catechol-acrylamide (9) (IC50= 5.1 +/- 0.6 microM), its 3,4,5-trihydroxy congener (10) (IC50= 1.7 +/- 0.2 microM), and the corresponding 3-methyl ether (11) (IC50= 9 +/- 3 microM). Increasing the length of the central alkyl spacer from ethyl to propyl (22-24) afforded essentially identical activity with IC50's of 1.7 +/- 0.2, 1.7 +/- 0.2, and 5 +/- 1 microM, respectively. No decrease in activity was noted until the introduction of a hexyl spacer. Our studies highlight the requirement for two free amido NHs with neither the mono-N-methyl (86) nor the bis-N-methyl (87) analogues inhibiting dynamin I GTPase. A similar effect was noted for the removal of the nitrile moieties. However, modest potency was observed with the corresponding ester analogues of 9-11: ethyl ester (90), propyl ester (91), and butyl ester (92), with IC50's of 42 +/- 3, 38 +/- 2, and 61 +/- 2 microM, respectively. Our studies reveal the most potent and promising dynamin I GTPase inhibitor in this series as (22), which is also known as BisT.
Similar articles
- Azido and diazarinyl analogues of bis-tyrphostin as asymmetrical inhibitors of dynamin GTPase.
Odell LR, Chau N, Mariana A, Graham ME, Robinson PJ, McCluskey A. Odell LR, et al. ChemMedChem. 2009 Jul;4(7):1182-8. doi: 10.1002/cmdc.200900054. ChemMedChem. 2009. PMID: 19437476 - Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
Hill TA, Gordon CP, McGeachie AB, Venn-Brown B, Odell LR, Chau N, Quan A, Mariana A, Sakoff JA, Chircop M, Robinson PJ, McCluskey A. Hill TA, et al. J Med Chem. 2009 Jun 25;52(12):3762-73. doi: 10.1021/jm900036m. J Med Chem. 2009. PMID: 19459681 - Development of second-generation indole-based dynamin GTPase inhibitors.
Gordon CP, Venn-Brown B, Robertson MJ, Young KA, Chau N, Mariana A, Whiting A, Chircop M, Robinson PJ, McCluskey A. Gordon CP, et al. J Med Chem. 2013 Jan 10;56(1):46-59. doi: 10.1021/jm300844m. Epub 2012 Dec 18. J Med Chem. 2013. PMID: 23167654 - Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis.
Hill TA, Mariana A, Gordon CP, Odell LR, Robertson MJ, McGeachie AB, Chau N, Daniel JA, Gorgani NN, Robinson PJ, McCluskey A. Hill TA, et al. J Med Chem. 2010 May 27;53(10):4094-102. doi: 10.1021/jm100119c. J Med Chem. 2010. PMID: 20426422 - [Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K. Tomioka H, et al. Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
- Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection.
Alkafaas SS, Abdallah AM, Ghosh S, Loutfy SA, Elkafas SS, Abdel Fattah NF, Hessien M. Alkafaas SS, et al. Rev Med Virol. 2023 Jan;33(1):e2403. doi: 10.1002/rmv.2403. Epub 2022 Nov 7. Rev Med Virol. 2023. PMID: 36345157 Free PMC article. Review. - Role of Clathrin and Dynamin in Clathrin Mediated Endocytosis/Synaptic Vesicle Recycling and Implications in Neurological Diseases.
Prichard KL, O'Brien NS, Murcia SR, Baker JR, McCluskey A. Prichard KL, et al. Front Cell Neurosci. 2022 Jan 18;15:754110. doi: 10.3389/fncel.2021.754110. eCollection 2021. Front Cell Neurosci. 2022. PMID: 35115907 Free PMC article. Review. - Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome.
Müller-Deile J, Teng B, Schenk H, Haller H, Reiser J, Sever S, Schiffer M. Müller-Deile J, et al. Ann Transl Med. 2016 Nov;4(21):439. doi: 10.21037/atm.2016.10.72. Ann Transl Med. 2016. PMID: 27942530 Free PMC article. No abstract available. - Identification of drug-like molecules targeting the ATPase activity of dynamin-like EHD4.
Mohd S, Oder A, Specker E, Neuenschwander M, Von Kries JP, Daumke O. Mohd S, et al. PLoS One. 2024 Jul 29;19(7):e0302704. doi: 10.1371/journal.pone.0302704. eCollection 2024. PLoS One. 2024. PMID: 39074100 Free PMC article. - Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase.
Robertson MJ, Deane FM, Robinson PJ, McCluskey A. Robertson MJ, et al. Nat Protoc. 2014 Apr;9(4):851-70. doi: 10.1038/nprot.2014.046. Epub 2014 Mar 20. Nat Protoc. 2014. PMID: 24651498
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous